K. Stein

NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia.

E. George, W. Miller, Joanne Holden, 2011, The Lancet. Oncology.

Health care utilization and costs in patients with early onset myelodysplastic syndrome in a commercially insured population.

M. Broder, A. Powers, K. Stein, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.